| October 2020 | M. Jeyanathan, S. Afkhami, F. Smaill, MS Miller, BD Lichty, Z Xing
M. Sharma M, RG Hart, JW Eikelboom, EM Lonn, S. Yusuf et al. | Nat Rev Immunol
Stroke | Immunological considerations for COVID-19 vaccine strategies. 2020 Oct;20(10):615-632.
Rivaroxaban for Prevention of Covert Brain Infarcts and Cognitive Decline: The COMPASS MRI Substudy. 2020 Oct;51(10):2901-2909. |
| September 2020 | CM Clase, M. Joseph, MB Dolovich et al. | Ann Intern Med | Cloth Masks May Prevent Transmission of COVID-19: An Evidence-Based, Risk-Based Approach.2020 Sep 15;173(6):489-491. |
| August 2020 | G. Pare, M. Sharma, A. Shoamanesh et al.
D. Arnold, N. Heddle, E. Jamula, W. Lim, J. Kelton, et al. | Stroke
Lancet Haematol | High-Sensitivity Cardiac Troponin T for Risk Stratification in Patients With Embolic Stroke of Undetermined Source. 2020 Aug;51(8):2386-2394.
Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial. 2020 Sep;7(9):e640-e648. |
| July 2020 | M. Zworth, C. Saleh, I. Ball, G. Kalles, S. Oczkowski et al. | BMJ Open | Provision of Medical Assistance in Dying: a Scoping Review 2020 Jul 8;10(7):e036054. |
June 2020 | S. Mithoowani, A. Cervi, N. Shah, E. Sirotich, I. Nazy, D. Arnold et al. | J Thromb Haemost | Management of Major Bleeds in Patients With Immune Thrombocytopenia. 2020 Jul;18(7):1783-1790. |
May 2020 | M. Mukherjee, A. Bhalla, J. Cherukat, H. Al-Hayyan, A. Ayoub, P. Nair et. al. | Eur Respir J | Sub-optimal Treatment Response to anti-IL-5 Monoclonal Antibodies in Severe Eosinophilic Asthmatics With Airway Autoimmune Phenomena. Eur Respir J. 2020 May 22;2000117. |
April 2020 | Drs. S. Anand, K. Schulze, K. Teo, S. Yusuf | Stroke | Reduced Cognitive Assessment Scores Among Individuals With Magnetic Resonance Imaging-Detected Vascular Brain Injury. Stroke. 2020 Apr;51(4):1158-1165. |
| March 2020 | Dr. I. Walker et al.
Drs. M. Pigeyre, S. Yusuf, H. Gerstein, G. Paré et al. | Lancet Hematology
Diabetes Care | Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with Haematological malignancies undergoing transplantation from unrelated donors; final analysis of a randomised, open-label, multicentre, phase 3 trial. Lancet Hematol. 2020 Feb;(7)2:e100-e111.
ACE and Type 2 Diabetes Risk: A Mendelian Randomization Study. Diabetes Care. 2020 Feb 4. pii: dc191973. |
| February 2020 | Dr. G. Steinberg et al. | Nat Rev Drug Discov | AMP-activated protein kinase: the current landscape for drug development. Nat Rev Drug Discov. 2019;18(7):527-551. |
| January 2020 | Drs. C. Kearon, K. de Wit, S. Schulman, F. Spencer, S. Bates et al.
Drs. A. Patel, F. Borges, G. Guyatt, W. Szczeklik, A. Garg, M. Walsh, S. Yusuf, PJ Devereaux et al. | NEJM
Ann Intern Med | Diagnosis of Pulmonary Embolism with D-Dimer Adjusted to Clinical Probability. N Engl J Med. 2019 Nov 28;381(22):2125-34.
Preoperative N-Terminal Pro-B Type Natriuretic Peptide and Cardiovascular Events After Noncardiac Surgery. 2020 Jan 21;172(2):96-104. |
| December 2019 | Drs. H. Gerstein, G. Pare et al. | Diabetes Care | Novel Biomarkers for Change in Renal Function in People with Dysglycemia. Diabetes Care. Epub 2019 Nov 14. |
| November 2019 | Drs. JD Schwalm, S. Yusuf et al.
| Lancet
| A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomized controlled trial. Lancet. 2019 Oct 5;394(10205):1231-42. |
| October 2019 | Drs. S. Yusuf, P. Joseph, S. Rangarajan, K. Teo, D. Leong, M. O'Donnell et al.
Drs. S. Mehta, T. Sheth, N. Pinilla-Echeverri et al. | Lancet
NEJM | Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. E-pub 2019 Sep 2.
Complete Revascularization with Multivessel PCI for Myocardial Infarction. NEJM. Epub 2019 Sep1. |
| September 2019 | Dr. H. Gerstein et al. | Lancet | Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind randomised placebo-controlled trial. Lancet. 2019 Jul 13;394(10193):121-130. |